tiprankstipranks
Damora Therapeutics (DMRA)
NASDAQ:DMRA
US Market
DMRA
Damora Therapeutics
RESEARCH TOOLSreports

Damora Therapeutics (DMRA) Income Statement

Compare
326 Followers

Damora Therapeutics Income Statement

Last quarter (Q2 2024), Damora Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Damora Therapeutics's net income was $-5.34M. See Damora Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -181.00K$ -830.00K$ -490.00K$ -441.00K$ -188.00K
Operating Expenses
$ 16.72M$ 35.63M$ 60.72M$ 51.79M$ 33.45M
Depreciation and Amortization
$ 181.00K$ 830.00K$ 490.00K$ 441.00K$ 188.00K
EBITDA
$ -16.72M$ -35.63M$ -60.72M$ -51.79M$ -33.45M
Operating Income
$ -16.90M$ -36.46M$ -61.21M$ -52.23M$ -33.64M
Other Income/Expenses
$ -4.50M$ -1.89M$ -417.00K$ 475.00K$ -1.20M
Pretax Income
$ -21.40M$ -38.35M$ -61.62M$ -51.75M$ -34.84M
Net Income
$ -21.44M$ -38.35M$ -61.62M$ -51.75M$ -34.84M
Per Share Metrics
Basic EPS
$ -18.53$ -36.08$ -60.63$ -51.22$ -34.48
Diluted EPS
$ -18.53$ -36.08$ -60.63$ -51.22$ -34.48
Weighted Average Shares Outstanding
 1.16M 1.06M 1.02M 1.01M 1.01M
Weighted Average Shares Outstanding (Diluted)
 1.16M 1.06M 1.02M 1.01M 1.01M
Currency in USD

Damora Therapeutics Earnings and Revenue History